Investment Trusts

Impact Healthcare REIT plc

IHR:LSE

Impact Healthcare REIT plc

Actions
  • Price (GBX)84.20
  • Today's Change1.00 / 1.20%
  • Shares traded1.74m
  • 1 Year change-7.17%
  • Beta0.4935
Data delayed at least 20 minutes, as of Mar 28 2024 17:55 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Total returns on £1000

1Y
Fund/benchmarkChange
PriceImpact Healthcare REIT plc (Ordinary Share)-0.79%
NAVImpact Healthcare REIT plc (Ordinary Share)+11.18%
Morningstar's BenchmarkFTSE EPRA Nareit NR--

Key statistics

On Thursday, Impact Healthcare REIT plc (IHR:LSE) closed at 84.20, 9.21% above its 52-week low of 77.10, set on Oct 26, 2023.
52-week range
Today
77.10Oct 26 2023102.85May 17 2023
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding414.37m
Market cap344.75m GBP
Total assets658.75m GBP
Total expense ratio1.51%
High84.80
Low82.90
Previous close83.20
Average volume784.00k
YTD Change-6.55%
Beta0.4935
Diluted NAV (est)114.28
Diluted NAV (last pub)114.22
Premium/Discount-26.32%
Net Gearing+35.10%
Annual div (ADY)6.77
GBX
Annual div yield (ADY)8.14%
Div ex-dateFeb 08 2024
Div pay-dateFeb 23 2024
Data delayed at least 20 minutes, as of Mar 28 2024 17:55 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.